WorldPharmaNews
  • Home
  • Business
  • Research
  • Events
  • Regulatory

Got a great idea? Submit yours to Grand Challenges Explorations

Details
Development
04 April 2012
The Bill & Melinda Gates Foundation is accepting applications for Round 9 of its Grand Challenges Explorations initiative, a USD$100 million grant initiative encouraging innovation in global health and development research. Anyone - students, scientists, entrepreneurs - with a transformative idea is invited to submit an easy, online, two-page application.
Read more ...

Rising Interest of Big Pharma Creates Immense Growth Potential for Contract Manufacturing Organisations

Details
Development
23 January 2012
Increasingly, big pharma is viewing the outsourcing of pharmaceutical manufacturing as a strategic move that would enable them to focus on their core competencies such as R&D. At the same time, the patent expiry of key blockbuster drugs worth $45 billion and biologics worth $30 billion is expected to reduce the capacity utilisation rates of their manufacturing facilities,
Read more ...

GE Healthcare and M+W Group form strategic alliance in vaccines, insulin and biopharmaceuticals

Details
Development
14 December 2011
GE Healthcare, the healthcare business of GE (NYSE: GE) and M+W Group, a leading global engineering, construction and project management company, have formed a strategic alliance aimed at overcoming the lack of key biopharmaceuticals, especially in emerging nations.
Read more ...

IBM Contributes Data to the National Institutes of Health to Speed Drug Discovery and Cancer Research Innovation

Details
Development
14 December 2011
IBM (NYSE: IBM) announced it is contributing a massive database of chemical data extracted from millions of patents and scientific literature to the National Institutes of Health. This contribution will allow researchers to more easily visualize important relationships among chemical compounds to aid in drug discovery and support advanced cancer research.
Read more ...

Springer Healthcare Announces Agreement With ASCO®

Details
Development
05 December 2011
Springer Healthcare, part of Springer Science+Business Media, has signed an extensive three-year reprints and sales agreement effective 1 January 2012 with the American Society of Clinical Oncology® (ASCO), the world's leading professional organization representing physicians who care for people with cancer.
Read more ...

Unparalleled global progress in HIV response but sustained investment vital

Details
Development
30 November 2011
Global progress in both preventing and treating HIV emphasizes the benefits of sustaining investment in HIV/AIDS over the longer term. The latest report by the World Health Organization (WHO), UNICEF and UNAIDS Report on the Global HIV/AIDS Response indicates that increased access to HIV services resulted in a 15% reduction of new infections over the past decade and a 22% decline in AIDS-related deaths in the last five years.
Read more ...

Bio-Images and Medimetrics Partner to Deliver the Next Generation of Smart Pill Technology

Details
Development
24 October 2011
Bio-Images Research and Medimetrics Personalized Drug Delivery have today announced a partnership to introduce the IntelliCap to the global pharmaceutical industry as a clinical research tool.
Read more ...

More Pharma News ...

  1. Innovative technology improves care and reduces costs
  2. ecancerHub - A New Approach to Cancer Communication
  3. Innovative Medicines Initiative (IMI) 4th Call 2011
  4. ASCO Launches Cancer.Net Mobile, a New App for iPhone, iPad, and iPod Touch
  5. Harvard Medical School Faculty Advances Drug Safety Research with IBM Business Analytics
  6. New potential drug targets discovered for preventing prostate cancer cell growth
  • Start
  • Prev
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • Next
  • End
Tahmeena

Business & Industry

  • Pfizer reports record full-year 2022 results
  • AMJEVITA™ (adalimumab-atto), first biosimilar to Humira® now available in the United States
  • CHMP recommends Bayer’s darolutamide for the treatment of metastatic hormone-sensitive prostate cancer
  • Roche announces the European Commission approval of Xofluza for the treatment and prevention of influenza in children aged one year and above
  • Pfizer expands 'An Accord for a Healthier World' product offering to include full portfolio for greater benefit to 1.2 billion people in 45 lower-income countries

Research & Development

  • Scientists pinpoint protein that helps cancer-causing viruses evade immune response
  • Transforming the way cancer vaccines are designed and made
  • Antidepressants used for chronic pain on the rise, but are they effective?
  • Keys to making immunotherapy work against pancreatic cancer found in tumor microenvironment
  • Discovery of anti-cancer chemistry makes skullcap fit for modern medicine
  • Coordination of COVID-19 vaccine clinical trials produces a 'treasure trove' of data and a model for the future
  • Power of cancer drugs may see boost by targeting newly ID'd pathway

Conferences & Events

  • SAE Media Group proudly presents the 4th Annual AI in Drug Discovery Conference
  • SAE Media Group's 6th annual 3D Cell Culture Conference
  • CPHI Frankfurt returns to pre-pandemic strength as pharma industry booms again
  • 14th Annual RNA Therapeutics: Investigating the next generation of genetic medicine through RNA based therapies
  • CPHI Excellence in Pharma Award Winners 2022
  • CPHI Frankfurt Report predicts huge funding overhang to drive contract services growth
  • CPHI Frankfurt 2022: Global pharma confidence hits record high in the annual CPHI Pharma Index

Regulatory Affairs

  • FDA grants Accelerated Approval for Alzheimer's disease treatment
  • FDA approves new HIV drug for adults with limited treatment options
  • FDA approves first gene therapy for the treatment of high-risk, non-muscle-invasive bladder cancer
  • FDA approves first gene therapy to treat adults with Hemophilia B
  • FDA approves first treatment for Acid Sphingomyelinase Deficiency, a rare genetic disease
  1. You are here:  
  2. Home
  3. Development
  4. Crowdfunding helps solve rare disease mystery

About

  • Home
  • Advertise
  • Privacy
  • Cookie Preferences
  • Terms of Use
  • Contact

Top News Channels

  • Industry
  • Research
  • Regulatory

Submit Your News!

Follow / Join us

Didn't we got you connected? If not, please note the following magic buttons:
  • Facebook
  • Twitter
  • LinkedIn
  • XING
  • RSS

Digest World Pharma Newsletter

Subscribe to our weekly Digest Newsletter and stay updated on the latest World Pharma News. Subscribe now, it's free!

© World Pharma News 2023. All Rights Reserved.